Detailed explanation of formal channels and prices for purchasing Avonib

Ivosidenib (Ivosidenib), as a targeted therapy for acute myeloid leukemia (AML) targeting IDH1 gene mutations, has been approved for marketing in China. By inhibiting the activity of IDH1 mutant enzyme, it can effectively improve the condition of patients, help some patients achieve clinical remission and improve their quality of life.

Ivonib has not yet been included in China's medical insurance, so the price is relatively high. Patients can purchase it through domestic hospital pharmacies or large drug chain stores. The specific price varies depending on the hospital, pharmacy and region, and is roughly around 30,000 to 40,000 yuan. It is recommended to consult your local hospital pharmacy before purchasing to obtain accurate price information.

In some foreign markets, such as Laos, the price of generic ivonib is relatively affordable, about RMB 6,000 to 7,000. Although the ingredients of generic drugs are similar to the original drugs, it is important to ensure the source is reliable when purchasing to ensure the quality and safety of the drugs.

When purchasing ivonib, patients should pay attention to the legality and source of the drug and avoid purchasing counterfeit or unapproved drugs. It is recommended to purchase through formal channels, such as certified hospital pharmacies or legal drug suppliers, and consult a doctor or pharmacist to ensure the suitability and correct usage of the drug.

In summary, ivonib is an effective targeted drug for the treatment of acute myeloid leukemia. When buying domestically, you need to pay attention to price and channels; although the price is lower when buying abroad, you need to ensure that the source of the medicine is reliable. Always consult a professional when purchasing to ensure the medicine is safe and effective.